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result of a point mutation (T to C) at nucleotide position 8851 of the
mitochondrial DNA (mtDNA). This mutation changes a highly
conserved tryptophane residue to arginine at amino acid position
109 of the subunit a of mitochondrial F1FO-ATP synthase, a complex
which provides most of the cellular ATP in humans. Nothing is
known on the consequences of the T8851C mutation on the
mitochondrial ATP synthase. To gain insight into the primary
pathogenic mechanisms induced by T8851C, we have investigated
the consequences of this mutation on the ATP synthase of yeast
where the protein homologous to subunit a (referred to as Atp6p) is
also encoded by the mtDNA. The modified yeast exhibited a very
slow growth phenotype on non-fermentable carbon sources, both at
28 °C (the optimal temperature for growing yeast) and at 36 °C. In
vitro, mitochondria from T8851C yeast grown at 28 °C showed a 60%
deficit in ATP production, while those prepared from the mutant
grown at 36 °C had an ATP synthesis activity below 5% that of the
wild type. The mutated F1FO complex was correctly assembled, at
both temperatures, and had a very poor ATPase activity (10% that
of the wild type), both in mitochondria and after purification.
Electron microscopy revealed that many of the mitochondrial
matrices in T8851C yeast grown at 36 °C exhibited septae made of
apposed inner mitochondrial membranes. Another anomaly was an
increased mitophagic activity, presumably in response to the
T8851C-induced damaging of mitochondria. Thus, in addition to a
bioenergetic deficit, alterations in mitochondrial dynamics and
homeostasis may also participate in the pathogenic mechanism
induced by T8851C.
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Mitochondrial disease is an energy metabolic disorder with
various organ involvements. Iron is widely known to be one of the
most important nutriments required for normal brain development
and several essential metabolic functions. We retrospectively studied
the laboratory data on iron deficiency (ID) in 69 children with
mitochondrial respiratory chain complex (MRC) defects by biochem-
ical enzyme assay using muscle tissue. We analyzed the differences
between groups of mitochondrial disease based on the presence of ID.
ID has higher prevalence in children with mitochondrial disease than
in the normal population. There were 6 (9%) patients with low
hemoglobin, 12 (17%) with low serum ferritin, and 22 (32%) with low
transferrin saturation levels among children with MRC defects. In
comparisons between the ID and the non-ID group of MRC-defect
patients, the frequency of MRC I defect was significantly higher in the
ID group while that of MRC IV defect was higher in the non-ID group.
Abnormal brain magnetic resonance imaging (MRI) findings were
more frequently detected in the ID group. The incidence of failure to
thrive and gastrointestinal symptoms were significantly higher in the
ID group. Early diagnosis and proper treatment of ID are recom-
mended. Especially in cases with risk factors such as failure to thrive
or gastrointestinal manifestation, active evaluation of ID should be
encouraged.
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Cytochrome c oxidase (COX, CIV) is one of the complexes of the
OXPHOS system located in the inner mitochondrial membrane and
catalyzing the last step of electron's transfer from cytochrome c to
molecular oxygen. It is composed of 13 subunits encoded by
mitochondrial and nuclear DNA. A correct assembly and function of
COX require a substantial number of the nuclear, ancillary proteins,
including SCO2, which is involved in the transport and incorporation
of the cooper ions to the CuA enzymatic site on COXII subunit. Human
SCO2 gene is located on the chromosome 22q13, and contains two
exons. Only the 801 bp fragment of exon 2 undergoes translation into
266 amino acid protein. Mutations in the SCO2 gene lead to serious
damage of the protein resulting in severe COX deficiency observed
mainly in muscle, heart and brain. The common substitution,
g.1541G>A (p.E140K) was identified at least on one allele in all so
far reported patients with COX deficiency. In the group of 23 Polish
patients, the common substitution was found on 84% of the studied
alleles. The clinical features of the disease associated with SCO2
deficiency include early onset, fatal hypertrophic cardiomyopathy
with respiratory insufficiency, encephalopathy, hypotonia and meta-
bolic acidosis. The aim of this study was to characterize the molecular
background of the disease in three patients from two unrelated
families with clinically and biochemically recognized cytochrome c
oxidase deficiency. Here we present patients with the same genotype,
comprising the common mutation, g.1541G>A and a new, not
described in the literature, molecular variant g.1653T>C. The new
variant affects the highly conserved methionine at 177 position of the
SCO2 protein (p.M177T) and was not found on 600 control alleles.
Additionally, g.1653T>C substitution was predicted by SIFT BLink
programme as a pathogenic mutation. Our findings indicate that the
compound heterozygous genotype, p.M177T/p.E140K, is responsible
for clinical manifestation of destroyed SCO2 protein.
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Leigh syndrome is most frequently caused by mutations of SURF1
gene, which encodes cytochrome c oxidase (COX) specific assembly
factor. Our previous studies suggested that fibroblasts from patients
harbouring SURF1 mutations accumulate incomplete forms of COX
lacking several small nuclear-encoded subunits with decreased H+/e
stoichiometry. In experiments aimed at detailed characterization of the
mitochondrial energetics, we observed 30–50% decreased respiratory
capacity available for ATP synthesis (RCRP). When using COX-specific
substrates ascorbate + TMPD, the RCRP was 7-fold lower than in
controls, suggestive of deficient proton pumping of COX in patient
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